Physician profile
David Cook
NPI 1548369655
$2,120.99
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,872 · 2020: $249.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,023.74 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $685.07 | 2019-2020 | |
| Eisai INC. | $101.82 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $63.72 | 2019 | |
| Alexion Pharmaceuticals, INC. | $41.09 | 2019 | |
| Zyla Life Sciences, INC. | $36.71 | 2019 | |
| Avanir Pharmaceuticals, INC. | $30.73 | 2019 | |
| Bausch Health US, LLC | $30.73 | 2019 | |
| Allergan, INC. | $28.82 | 2020 | |
| Lilly USA, LLC | $25.30 | 2019 | |
| Assertio Therapeutics, INC. | $23.41 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.97 | 2019 | |
| Supernus Pharmaceuticals, INC. | $12.88 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.